[Drug-induced hypersensitivity syndrome: DIHS].
Department of Dermatology, Ehime University Graduate School of Medicine. tohm@m-ehime-u.ac.jp
Mikiko
M
Tohyama
Koji
K
Hashimoto
D000493:Allopurinol / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects*; D002220:Carbamazepine / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000821:virology; D004342:Drug Hypersensitivity / Q000209:etiology* / Q000821:virology; D015654:Herpesvirus 6, Human / Q000502:physiology; D006801:Humans; D012997:Solvents / Q000009:adverse effects; D012460:Sulfasalazine / Q000009:adverse effects; D013577:Syndrome; D013601:T-Lymphocytes / Q000276:immunology / Q000821:virology; D014241:Trichloroethylene / Q000009:adverse effects; D014775:Virus Activation
D000927:Anticonvulsants; D012997:Solvents; D014241:Trichloroethylene; D002220:Carbamazepine; D012460:Sulfasalazine; D000493:Allopurinol